Below are the most recent publications written about "Gels" by people in Profiles.
-
Shingade K, Sutar Y, Annaji M, Kulkarni M, Date AA. Borneol-caprylic acid deep eutectic solvent (DES) based microemulsion gel for improved topical delivery of ivermectin. Int J Pharm. 2026 May 05; 696:126819.
-
Mallick S, Sharma P, Yadavalli T, Koganti R, Singh SK, Yoshimura K, Kapoor D, Sutar Y, Adams JS, Annaji M, Shukla D, Date AA. Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infection. Int J Pharm. 2026 Apr 25; 695:126672.
-
Chuang AE, Lin YW, Jheng PR, Rethi L, Nguyen HT, Weng PW. Bio-intelligent plasma-engineered diferuloylmethane/fucoidan/neutrophil lysate/iron oxide nanoclusters for phototherapeutic and magnetotherapeutic with in situ magnetic gelation mitigating inflammatory diseases. Colloids Surf B Biointerfaces. 2024 Nov; 243:114054.
-
Badruddoza AZM, Zahid MI, Walsh T, Shah J, Gates D, Yeoh T, Nurunnabi M. Topical drug delivery by Sepineo P600 emulgel: Relationship between rheology, physical stability, and formulation performance. Int J Pharm. 2024 Jun 10; 658:124210.
-
Roman B, Kumar SA, Allen SC, Delgado M, Moncayo S, Reyes AM, Suggs LJ, Chintalapalle R, Li C, Joddar B. A Model for Studying the Biomechanical Effects of Varying Ratios of Collagen Types I and III on Cardiomyocytes. Cardiovasc Eng Technol. 2021 06; 12(3):311-324.
-
Kim YC, Shin MD, Hackett SF, Hsueh HT, Lima E Silva R, Date A, Han H, Kim BJ, Xiao A, Kim Y, Ogunnaike L, Anders NM, Hemingway A, He P, Jun AS, McDonnell PJ, Eberhart C, Pitha I, Zack DJ, Campochiaro PA, Hanes J, Ensign LM. Gelling hypotonic polymer solution for extended topical drug delivery to the eye. Nat Biomed Eng. 2020 11; 4(11):1053-1062.
-
Kulkarni M, Hastak V, Jadhav V, Date AA. Fenugreek Leaf Extract and Its Gel Formulation Show Activity Against Malassezia furfur. Assay Drug Dev Technol. 2020 01; 18(1):45-55.
-
Liu AY, Norwood A, Gundacker H, Carballo-Di?guez A, Johnson S, Patterson K, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Mayer KH, Zorrilla C, Buchbinder S, Piper JM, Lama JR, Cranston RD. Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017). J Acquir Immune Defic Syndr. 2019 08 15; 81(5):516-520.
-
Carballo-Di?guez A, Giguere R, Dolezal C, Leu CS, Bal?n IC, Brown W, Rael C, Richardson BA, Piper JM, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu A, Mayer KH, Zorrilla CD, Lama JR, McGowan I, Cranston RD. Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men. AIDS Behav. 2017 Dec; 21(12):3336-3345.
-
Carballo-Di?guez A, Bal?n IC, Brown W, Giguere R, Dolezal C, Leu CS, Marzinke MA, Hendrix CW, Piper JM, Richardson BA, Grossman C, Johnson S, Gomez K, Horn S, Kunjara Na Ayudhya RP, Patterson K, Jacobson C, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu A, Mayer KH, Zorrilla C, Lama J, McGowan I, Cranston RD. High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women. PLoS One. 2017; 12(7):e0181607.